United States Antimony (UAMY) Cash & Equivalents (2010 - 2025)

United States Antimony has disclosed Cash & Equivalents across 16 years of filings, most recently posting $30.5 million for Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $30.5 million, up 67.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.5 million (up 67.81% YoY), and the FY2025 annual result was $30.5 million, up 67.81% from the prior year.
• Cash & Equivalents came in at $30.5 million for Q4 2025 at United States Antimony, up from $18.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $30.5 million in Q4 2025 to a low of $5.8 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $16.8 million (2023), against an average of $16.4 million.
• Across the five-year window, Cash & Equivalents surged 100037.01% in 2021 and plunged 64.31% in 2022, its largest moves.
• United States Antimony's Cash & Equivalents stood at $21.4 million in 2021, then dropped by 10.75% to $19.1 million in 2022, then tumbled by 37.47% to $12.0 million in 2023, then soared by 52.01% to $18.2 million in 2024, then jumped by 67.81% to $30.5 million in 2025.
• The last three Cash & Equivalents figures came in at $30.5 million (Q4 2025), $18.3 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.